Leica Biosystems launches the Leica CM1950 Cryostat with DualEcoTec Cooling System
With up to 50% lower energy consumption compared to previous models, laboratories benefit from operating cost savings and reduced environmental impact
With up to 50% lower energy consumption compared to previous models, laboratories benefit from operating cost savings and reduced environmental impact
Tahoe Therapeutics aims to use the speed and accuracy of these automated systems to generate a dataset fifty times larger than its already record-breaking Tahoe 100 million single-cell atlas
A computer simulation technique known as molecular dynamics will be used to study how G-protein-coupled receptors interact with the intracellular effector inside the cell
EpiFinder Analysis Service establishes a new standard for accessible, end-to-end epigenomic analysis, enabling researchers to move confidently from study concept to biological insights
In our SelectScience NGS Forum, genomics leaders discussed the challenges and opportunities driving the next chapter of next-generation sequencing
How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics
This 7th edition eBook provides useful resources, expert insights, and application-based case studies to help simplify your choice when it comes to selecting the best cell counting technology. Learn about key factors and application considerations for your counting needs. Plus, read lab product reviews from your peers to help you buy with confidence.
The new agents are the AI Protocol Conversion agent and the AI Automation agent
New funding accelerates platform development and meets surging demand as pharma and biotech reimagine drug discovery
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
As an ambassador for the Women in STEM Network, Dr. Vasiliki E. Kalodimou is mentoring future scientists and redefining what is possible for women
Newly patented MICRO‑TAG platform brings real‑time, in‑cell target engagement to the forefront of drug discovery
New research and clinical evidence are redefining how clinicians detect and manage preeclampsia, with angiogenic biomarker testing offering earlier, clearer insight into maternal risk